{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 20
    }
  },
  "results": [
    {
      "discontinued_date": "05/15/2026",
      "update_type": "New",
      "initial_posting_date": "05/15/2026",
      "package_ndc": "0574-0520-74",
      "generic_name": "Activated Charcoal Oral Suspension",
      "contact_info": "866-634-9120",
      "related_info": "Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "M023"
        ],
        "brand_name": [
          "ACTIDOSE"
        ],
        "generic_name": [
          "ACTIVATED CHARCOAL"
        ],
        "manufacturer_name": [
          "Padagis US LLC"
        ],
        "product_ndc": [
          "0574-0520"
        ],
        "product_type": [
          "HUMAN OTC DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ACTIVATED CHARCOAL"
        ],
        "rxcui": [
          "309150",
          "1251411"
        ],
        "spl_id": [
          "cf3da077-fe7d-4685-8c5c-f773bc88c88d"
        ],
        "spl_set_id": [
          "76e4fe6a-afd4-4f68-b12d-0b094f750615"
        ],
        "package_ndc": [
          "0574-0520-74",
          "0574-0520-76"
        ],
        "unii": [
          "2P3VWU3H10"
        ]
      },
      "update_date": "05/15/2026",
      "therapeutic_category": [
        "Other"
      ],
      "dosage_form": "Oral Suspension",
      "presentation": "Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-74)",
      "company_name": "Padagis US LLC",
      "status": "To Be Discontinued"
    }
  ]
}